These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 22188557)

  • 41. Comparability of single measurements of serum testosterone to the 24-hour C(avg) in patients using testosterone 2% solution.
    Muram D; Baygani S
    J Sex Med; 2014 Nov; 11(11):2826-9. PubMed ID: 25123851
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetics of testosterone and estradiol gel preparations in healthy young men.
    Eisenegger C; von Eckardstein A; Fehr E; von Eckardstein S
    Psychoneuroendocrinology; 2013 Feb; 38(2):171-8. PubMed ID: 22721608
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.
    Darwish M; Tempero K; Kirby M; Thompson J
    Clin Ther; 2006 May; 28(5):715-24. PubMed ID: 16861093
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Therapeutically equivalent pharmacokinetic profile across three application sites for AG200-15, a novel low-estrogen dose contraceptive patch.
    Stanczyk FZ; Archer DF; Rubin A; Foegh M
    Contraception; 2013 Jun; 87(6):744-9. PubMed ID: 23228503
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetics of a new transdermal testosterone gel in gonadotrophin-suppressed normal men.
    Rolf C; Kemper S; Lemmnitz G; Eickenberg U; Nieschlag E
    Eur J Endocrinol; 2002 May; 146(5):673-9. PubMed ID: 11980623
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of food composition on serum testosterone levels after oral administration of Andriol Testocaps.
    Schnabel PG; Bagchus W; Lass H; Thomsen T; Geurts TB
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):579-85. PubMed ID: 17371478
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Absorption, bioavailability, and partner transfer of estradiol from a topical emulsion.
    Taylor MB; Gutierrez MJ
    Pharmacotherapy; 2008 Jun; 28(6):712-8. PubMed ID: 18503399
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy and safety of the 2% formulation of testosterone topical solution applied to the axillae in androgen-deficient men.
    Wang C; Ilani N; Arver S; McLachlan RI; Soulis T; Watkinson A
    Clin Endocrinol (Oxf); 2011 Dec; 75(6):836-43. PubMed ID: 21689131
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effects of treating male hypogonadism on couples' sexual desire and function.
    Conaglen JV; Conaglen HM
    J Sex Med; 2009 Feb; 6(2):456-63. PubMed ID: 19215616
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetic comparison of a new glimepiride 1-mg + metformin 500-mg combination tablet formulation and a glimepiride 2-mg + metformin 500-mg combination tablet formulation: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy, fasting Korean male volunteers.
    Kim BH; Shin KH; Kim J; Lim KS; Kim KP; Kim JR; Cho JY; Shin SG; Jang IJ; Yu KS
    Clin Ther; 2009 Nov; 31(11):2755-64. PubMed ID: 20110017
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transdermal delivery of testosterone.
    Hadgraft J; Lane ME
    Eur J Pharm Biopharm; 2015 May; 92():42-8. PubMed ID: 25709060
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of the pharmacokinetic profiles of the new testosterone topical gel formulation, Testim, compared to AndroGel.
    Marbury T; Hamill E; Bachand R; Sebree T; Smith T
    Biopharm Drug Dispos; 2003 Apr; 24(3):115-20. PubMed ID: 12673669
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M
    Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacokinetic properties of fentanyl effervescent buccal tablets: a phase I, open-label, crossover study of single-dose 100, 200, 400, and 800 microg in healthy adult volunteers.
    Darwish M; Kirby M; Robertson P; Tracewell W; Jiang JG
    Clin Ther; 2006 May; 28(5):707-14. PubMed ID: 16861092
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Profile of serum testosterone levels after application of testosterone ointment (glowmin) and its clinical efficacy in late-onset hypogonadism patients.
    Amano T; Imao T; Takemae K; Iwamoto T; Yamakawa K; Baba K; Nakanome M; Sugimori H; Tanaka T; Yoshida K; Katabami T; Tanaka M
    J Sex Med; 2008 Jul; 5(7):1727-36. PubMed ID: 18093097
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacokinetics of gabapentin after a single day and at steady state following the administration of gastric-retentive- extended-release and immediate-release tablets: a randomized, open-label, multiple-dose, three-way crossover, exploratory study in healthy subjects.
    Gordi T; Hou E; Kasichayanula S; Berner B
    Clin Ther; 2008 May; 30(5):909-16. PubMed ID: 18555937
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Amount of Testosterone on Laundered Clothing After Use of Testosterone Topical 2% Solution by Healthy Male Volunteers.
    Satonin DK; Ni X; Mitchell MI; Joly H; Muram D; Small DS
    J Sex Med; 2016 Feb; 13(2):187-93. PubMed ID: 26803453
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Safety and pharmacokinetics of NXN-188 after single and multiple doses in five phase I, randomized, double-blind, parallel studies in healthy adult volunteers.
    Vaughan D; Speed J; Medve R; Andrews JS
    Clin Ther; 2010 Jan; 32(1):146-60. PubMed ID: 20171420
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men.
    Wang C; Swerdloff RS; Iranmanesh A; Dobs A; Snyder PJ; Cunningham G; Matsumoto AM; Weber T; Berman N;
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2839-53. PubMed ID: 10946892
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Spuriously elevated testosterone measurements caused by application of testosterone gel at or near the phlebotomy site.
    Kirk D; Misita C
    Ann Pharmacother; 2013 Jan; 47(1):e5. PubMed ID: 23324503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.